» Articles » PMID: 35285093

Effects of Rosmarinic Acid on the Inflammatory Response in Allergic Rhinitis Rat Models After PM2.5 Exposure

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2022 Mar 14
PMID 35285093
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have shown the promising prospects of rosmarinic acid (RosA) for the prevention and treatment of allergic diseases.

Objective: The aim of this study was to investigate the effects of RosA on inflammatory reaction in rat models of allergic rhinitis (AR) after PM2.5 exposure.

Methods: Allergic rhinitis rat models were established by ovalbumin sensitization, and PM2.5 was applied at a concentration of 1000 μg/m , 3 h a day for 30 consecutive days. RosA was administered via intraperitoneal injection (20 mg/kg/d) for seven consecutive days. Allergic nasal symptoms were recorded. The expressions of interleukin (IL)-4, IL-13, interferon (INF)-γ, and OVA-sIgE were determined by ELISA. Histopathological changes in nasal mucosa were observed by HE staining. mRNA expressions of T-bet and GATA-3 in nasal mucosa were detected by RT-PCR. NF-κBp65 in cell nuclei and IκBα in cytoplasm were analyzed by Western blot.

Results: PM2.5 exposure worsened allergic nasal symptoms in AR rats, while RosA ameliorated these symptoms. Histopathologically, AR rats exhibited disorganized nasal mucosal epithelium, cell exfoliation, eosinophilic infiltration of lamina propria, gland swelling, and submucosal vascular congestion, which were aggravated by PM2.5 exposure and alleviated by RosA. RosA decreased the expressions of IL-4, IL-13, and increased the level of IFN-γ in PM2.5-exposed AR rats. After RosA intervention, the expressions of GATA-3 mRNA and NF-κBp65 in PM2.5-exposed AR rats were significantly reduced, while those of T-bet mRNA and IκBα were markedly increased.

Conclusion: Rosmarinic acid may alleviate symptoms of AR rat models exposed to PM2.5 through the modulation of the NF-κB pathway and Th1/Th2 balance.

Citing Articles

The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases.

Zareba L, Piszczatowska K, Dzaman K, Soroczynska K, Motamedi P, Szczepanski M J Pers Med. 2024; 14(1).

PMID: 38248800 PMC: 10817350. DOI: 10.3390/jpm14010098.


A Combined NMR and UV-Vis Approach to Evaluate Radical Scavenging Activity of Rosmarinic Acid and Other Polyphenols.

Kola A, Vigni G, Baratto M, Valensin D Molecules. 2023; 28(18).

PMID: 37764405 PMC: 10536562. DOI: 10.3390/molecules28186629.


Hepatoprotective Effects of Rosmarinic Acid on Ovalbumin-Induced Intestinal Food Allergy Mouse Model.

Jia B, Shang J, Zeng H, Wang X, Fang M, Xu L Molecules. 2023; 28(2).

PMID: 36677846 PMC: 9862803. DOI: 10.3390/molecules28020788.


Effects of rosmarinic acid on the inflammatory response in allergic rhinitis rat models after PM2.5 exposure.

Zhou L, Huang Y, Han Z, Wang J, Sun N, Zhang R J Clin Lab Anal. 2022; 36(4):e24316.

PMID: 35285093 PMC: 8993598. DOI: 10.1002/jcla.24316.

References
1.
Fan X, Zeng Q, Li X, Li C, Xu Z, Deng X . Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients. Stem Cell Res Ther. 2018; 9(1):170. PMC: 6010028. DOI: 10.1186/s13287-018-0896-z. View

2.
Minai-Fleminger Y, Levi-Schaffer F . Mast cells and eosinophils: the two key effector cells in allergic inflammation. Inflamm Res. 2009; 58(10):631-8. DOI: 10.1007/s00011-009-0042-6. View

3.
Cheng L, Chen J, Fu Q, He S, Li H, Liu Z . Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res. 2018; 10(4):300-353. PMC: 6021586. DOI: 10.4168/aair.2018.10.4.300. View

4.
Lindell E, Svensjo M, MALM L, Petersson G . Tachykinin-induced nasal fluid secretion and plasma exudation in the rat: effects of peptidase inhibition. Neuropeptides. 1995; 28(5):309-15. DOI: 10.1016/0143-4179(95)90047-0. View

5.
Shirkani A, Mansouri A, Hosseini R, Jabbari Azad F, Mahmoudian R, Montazer M . The Role of Interleukin-4 and 13 Gene Polymorphisms in Allergic Rhinitis: A Case Control Study. Rep Biochem Mol Biol. 2019; 8(2):111-118. PMC: 6844616. View